The Department of Health and Human Services is endorsing self-collected vaginal samples for cervical cancer screening and requiring most private insurance plans to cover testing without cost sharing.
The U.S. Food and Drug Administration has approved at-home tests for human papillomavirus (HPV), a virus linked to cervical cancer. The move aims to make screening more accessible, particularly for ...